Sonoma Pharmaceuticals Inc. buy me8
Start price
03.05.22
/
0%
€3.74
Target price
03.05.23
€5.00
Performance (%)
-12.63%
End price
14.05.22
€3.27
Summary
This prediction ended on 14.05.22 with a price of €3.27. The price of Sonoma Pharmaceuticals Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -12.63%. This prediction was marked as speculative and is excluded from me8's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Sonoma Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% | 69.888% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% | 101.814% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% | 45.300% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% | 63.763% |
According to me8 what are the pros and cons of Sonoma Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Very capable Management
Very good company culture
Cons
Few uniques
Comments by me8 for this prediction
In the thread Sonoma Pharmaceuticals, Inc. diskutieren
Buy Sonoma Pharmaceuticals Inc.
Kursziel gesetzt auf 5,0
In the thread Trading Sonoma Pharmaceuticals, Inc.
Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.